Successful treatment of X-linked lymphoproliferative disease (XLP) with anti-CD20 monoclonal antibody (Rituximab) followed by mismatched unrelated cord blood transplantation
T. L. Lee, Ka Wai Helen Law, G. C.F. Chan, S. Y. Ha, M. H.K. Ho, K. W. Chan, Y. L. Lau
Research output: Journal article publication › Journal article › Academic research › peer-review
Dive into the research topics of 'Successful treatment of X-linked lymphoproliferative disease (XLP) with anti-CD20 monoclonal antibody (Rituximab) followed by mismatched unrelated cord blood transplantation'. Together they form a unique fingerprint.